HomeDrug ClassesIntegrin Antagonists

Integrin Antagonists: Uses, Common Brands, and Safety Info

Integrin antagonists are a class of drugs that block the action of integrins on cell surfaces. They are used to treat inflammatory conditions and prevent blood clot formation. Common brands include Humira and Entyvio. While generally well-tolerated, these drugs can cause side effects such as headache and infections. Close monitoring is necessary for their safe use.

Drug Class: Integrin Antagonists

Integrin antagonists are a class of drugs that work by blocking the action of integrins, which are proteins found on the surface of cells. Integrins play a crucial role in cell adhesion and signaling, and by inhibiting their activity, integrin antagonists can interfere with various cellular processes. These drugs have shown promise in the treatment of several medical conditions and are available under different brand names.


Integrin antagonists have been primarily used in the management of certain inflammatory and autoimmune disorders. They have shown efficacy in reducing inflammation and modulating immune responses, making them valuable in the treatment of conditions such as:

  • Rheumatoid arthritis

  • Crohn's disease

  • Psoriasis

  • Multiple sclerosis

In addition to their role in managing inflammatory conditions, integrin antagonists have also demonstrated usefulness in preventing blood clot formation by inhibiting platelet aggregation. This property has led to their application in preventing cardiovascular events, specifically in patients at high risk of stroke or heart attack.

Common Brands

There are several integrin antagonists available on the market, each with its own unique brand name. Some commonly prescribed integrin antagonists include:

  • Adalimumab (brand name: Humira)

  • Abatacept (brand name: Orencia)

  • Vedolizumab (brand name: Entyvio)

  • Natalizumab (brand name: Tysabri)

It is important to note that the availability of specific brands may vary depending on the country and healthcare system.


Prior to initiating treatment with integrin antagonists, it is crucial to consider the safety profile of these drugs. While generally well-tolerated, integrin antagonists may be associated with certain risks and side effects. The most common adverse effects include:

  • Headache

  • Nausea or stomach upset

  • Fatigue

  • Infections

  • Allergic reactions

  • Increased risk of certain infections

As with any medication, it is important to discuss potential risks and benefits with a healthcare professional before starting treatment with integrin antagonists. Individuals with a history of certain infections or compromised immune function should exercise caution when using these drugs. Close monitoring and regular follow-up visits are often required to ensure the medication's effectiveness and safety over time.

Overall, integrin antagonists have demonstrated significant therapeutic potential in the management of inflammatory and autoimmune conditions. However, individual response to these drugs may vary, and treatment plans should be tailored to each patient's specific needs and medical history.